Detalhe da pesquisa
1.
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models.
Proc Natl Acad Sci U S A;
120(6): e2219199120, 2023 02 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36724255
2.
Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas.
Curr Neurol Neurosci Rep;
24(2): 17-25, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38170429
3.
Medical and Neurological Management of Brain Tumor Complications.
Curr Neurol Neurosci Rep;
21(10): 53, 2021 09 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34545509
4.
Lower Grade Gliomas.
Curr Neurol Neurosci Rep;
20(7): 21, 2020 05 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32444979
5.
Pattern reversal visual evoked potentials in adults: variability with age.
Clin Invest Med;
40(6): E252-E259, 2017 Dec 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29256391
6.
Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence.
Clin Transl Radiat Oncol;
44: 100697, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38046107
7.
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.
Clin Cancer Res;
30(7): 1327-1337, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38252427
8.
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity.
Neuro Oncol;
25(6): 1100-1112, 2023 06 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36402744
9.
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.
Neuro Oncol;
25(6): 1017-1028, 2023 06 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36617262
10.
Evaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppression.
Neurooncol Adv;
5(1): vdad083, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37554224
11.
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma.
J Clin Oncol;
41(17): 3160-3171, 2023 06 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37027809
12.
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
J Clin Oncol;
41(33): 5187-5199, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37774317
13.
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making.
Neuro Oncol;
24(7): 1140-1149, 2022 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34878541
14.
Ipilimumab: an investigational immunotherapy for glioblastoma.
Expert Opin Investig Drugs;
29(11): 1187-1193, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32945231
15.
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory.
Neurooncol Adv;
1(1): vdz009, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31608328
16.
Improved survival among females and association with lymphopenia in patients with newly diagnosed glioblastoma.
Neuro Oncol;
24(11): 2005-2007, 2022 11 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35973053
17.
Antitumor immune response during glioma virotherapy.
Neuro Oncol;
21(9): 1087-1088, 2019 09 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31348516